Ellis Van Creveld syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:289OMIM:619143Q77.6
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Ellis-van Creveld syndrome (EVC syndrome), also known as chondroectodermal dysplasia or mesoectodermal dysplasia, is a rare genetic skeletal disorder characterized by a combination of short-limb dwarfism, polydactyly, ectodermal dysplasia, and congenital heart defects. The condition is present at birth and affects multiple body systems including the skeletal system, heart, teeth, nails, and hair. It was first described by Richard Ellis and Simon van Creveld in 1940 and is notably more prevalent in the Old Order Amish population of Lancaster County, Pennsylvania, due to a founder effect. The hallmark skeletal features include disproportionate short stature with progressive shortening of the limbs from proximal to distal segments (acromesomelic shortening), postaxial polydactyly (extra fingers on the pinky side of the hand), and a narrow thorax with short ribs. Ectodermal abnormalities include small, dysplastic nails, sparse or fine hair, and dental anomalies such as natal teeth, delayed eruption, small teeth, and partial anodontia. A distinctive oral finding is the presence of multiple frenula or a fusion of the upper lip to the gum (lip tie), obliterating the upper labial sulcus. Approximately 50–60% of affected individuals have congenital heart defects, most commonly a single atrium or large atrial septal defect, which is the primary determinant of prognosis and can be life-threatening in infancy. Ellis-van Creveld syndrome is caused by pathogenic variants in the EVC or EVC2 (also called LIMBIN) genes located on chromosome 4p16, which encode proteins involved in Hedgehog signaling and are essential for normal skeletal and cardiac development. There is no cure for the condition, and management is multidisciplinary and supportive. Treatment may include surgical correction of congenital heart defects, orthopedic interventions for skeletal abnormalities including polydactyly removal, dental care for the ectodermal manifestations, and monitoring of respiratory function in infants with a narrow thorax. With appropriate cardiac management, many individuals survive into adulthood, though adult height is typically reduced, ranging from approximately 109 to 155 cm.

Also known as:

Clinical phenotype terms— hover any for plain English:

Foot polydactylyHP:0001829Nail dysplasiaHP:0002164Atrioventricular canal defectHP:0006695Neonatal short-limb short statureHP:0008921Abnormal oral mucosa morphologyHP:0011830
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Ellis Van Creveld syndrome.

View clinical trials →

No actively recruiting trials found for Ellis Van Creveld syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Ellis Van Creveld syndrome community →

No specialists are currently listed for Ellis Van Creveld syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Ellis Van Creveld syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Ellis Van Creveld syndromeForum →

No community posts yet. Be the first to share your experience with Ellis Van Creveld syndrome.

Start the conversation →

Latest news about Ellis Van Creveld syndrome

No recent news articles for Ellis Van Creveld syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Ellis Van Creveld syndrome

What is Ellis Van Creveld syndrome?

Ellis-van Creveld syndrome (EVC syndrome), also known as chondroectodermal dysplasia or mesoectodermal dysplasia, is a rare genetic skeletal disorder characterized by a combination of short-limb dwarfism, polydactyly, ectodermal dysplasia, and congenital heart defects. The condition is present at birth and affects multiple body systems including the skeletal system, heart, teeth, nails, and hair. It was first described by Richard Ellis and Simon van Creveld in 1940 and is notably more prevalent in the Old Order Amish population of Lancaster County, Pennsylvania, due to a founder effect. The h

How is Ellis Van Creveld syndrome inherited?

Ellis Van Creveld syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Ellis Van Creveld syndrome typically begin?

Typical onset of Ellis Van Creveld syndrome is neonatal. Age of onset can vary across affected individuals.